Align Technology, Inc. vs iShares MSCI Canada (TSX) — how do they compare? Align Technology, Inc. trades at $174.11 (market cap $12.29B), while iShares MSCI Canada (TSX) trades at $61.73. The key difference: iShares MSCI Canada (TSX) is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | EWC | |
|---|---|---|
Market Cap | $12.29B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $197.51 | $61.51 |
52-Week Low | $124.88 | $47.00 |
Enterprise Value | $11.30B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $173.4, down 1.5% today, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, a P/E of 30.03, and a net income margin of 9.99%. Recent news highlights a patent win in China and strategic initiatives under activist investor engagement, supporting its digital orthodontics leadership.
Outlook remains positive due to solid profitability and growth initiatives, but risks include competitive pressures and scanner segment weakness. Analyst consensus is strongly bullish with 73% buy ratings, viewing current valuation as attractive for long-term growth despite near-term technical headwinds.
EWC trades at $61.72, up 0.35% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF remains focused on Canadian equities, showing double-digit returns in 2026 but trailing the S&P 500. Recent news highlights trade tensions with the U.S., including potential 50% tariffs on Canadian goods, though key sectors like energy are exempt.
Outlook is mixed: bullish technicals and strong 2026 performance support upside, but trade war risks and overbought conditions pose near-term headwinds. Investors should weigh Canada's economic resilience against tariff uncertainties for balanced exposure.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.
Read more on EWC →